Patterns of Health Care Spending in Prostate Cancer
JAMA Network Open 10.1001/jamanetworkopen.2026.33031September 10, 2026 at 11:00 AM EDT
In this economic evaluation of SEER-Medicare data, spending for prostate cancer–related health care increased substantially from 2012 to 2021, with a marked shift toward systemic therapy. These findings suggest that prolonged systemic treatment has become a dominant component of prostate cancer spending and should be central to future discussions of health care sustainability.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.